摘要
肾病综合征(NS)患者易并发血栓栓塞(TE)。低分子肝素(LMWH)作为新一代抗凝剂,应用于NS不仅能防治TE,而且具有非抗凝性肾脏保护作用。笔者就LMWH在NS中的应用作一概述。
出处
《军医进修学院学报》
CAS
北大核心
2006年第6期478-480,共3页
Academic Journal of Pla Postgraduate Medical School
参考文献10
-
1Hong SY,Yang DH.Lipoprotein(a)levels and fibrinolytic activity in patients with nephrotic syndrome[J].Nephron,1995,69(1):125-130.
-
2Yeo Wook Yun,Sun-Jin You,Dong Kyu Lee,et al.Cerebral infarction as a complication of nephrotic syndrome:A case report with a review of the literature[J].J Korean Med Sci,2004,19:315-319.
-
3Buller HR,Agnelli G,Hull RD,et al.Antithrombotic therapy for venous thromboembolic disease:the seventh ACCP conference on antithrombotic and thrombolytic therapy[J].Chest,2004,126(suppl):401S-428S.
-
4Farooq V,Hegarty J,Chandrasekar T,et al.Serious adverse incidents with the usage of low molecular weight heparins in patients with chronic kidney disease[J].Am J Kidney Dis,2004,43(3):531-537.
-
5Nagge J,Crowther M,Hirsh J.Is impaired renal function a contraindication to the use of low-molecular-weight heparin[J] ? Arch Intern Med,2002,162(22):2605-2609.
-
6Duplaga BA,Rivers CW,Nutescu E.Dosing and monitoring of low-molecular-weight heparins in special populations[J].Pharmacotherapy,2001,21:218-234.
-
7Samama MM,Gerotziafas GT.Comparative pharmacokinetics of LMWHs[J].Semin Thromb Hemost,2000,26:S31-S38.
-
8Greaves M.Limitations of the laboratory monitoring of heparin therapy[J].Thromb Haemost,2002,87:163-164.
-
9Weitz JI.New anticoagulants for treatment of venous thromboembolism[J].Circulation,2004,110(9 Suppl 1):119-126.
-
10Becker RC,Rusconi C,Sullenger B.Nucleic acid aptamers in therapeutic anticoagulation.Technology,development and clinical application[J].Thromb-Haemost,2005,93(6):1014-1020.
同被引文献39
-
1贺丽生,谌贻璞.吗替麦考酚酯联合激素治疗膜性肾病的临床观察[J].临床肾脏病杂志,2007,7(1):1-4. 被引量:3
-
2王海燕.肾脏病学[M].3版.北京:人民卫生出版社,2008:8262.
-
3Narasimhan B, Chacko B, John GT, et al. Characterization of kid- ney lesions in Indian adults : towards a renal biopsy registry [ J ]. J Nephrol, 2006,19 ( 2 ) : 205 -210.
-
4Chang JH, Kim DK, Kim HW, et al. Changing prevalence of glo- merular diseases in Korean adults : a review of 20 years of experi- ence [ J ]. N ephrol Dial Transpl ant, 2009,24 ( 8 ) : 2406 -2410.
-
5Swaminathan S, Leung N, Lager DJ, et al. Changing incidence of glomerular disease in Olmsted County, Minnesota: a 30-year renal biopsy study [ J ]. Clin J Am Soc Nephrol, 2006,1 (3) :483-487.
-
6Kurnatowska I,Jedrzejka D, Malyska A,et al. Trends in the inci- dence of biopsy- proven glomerular diseases in the adult population in central Poland in the years 1990-2010 [J]. Kidney Blood Press Res ,2012,35 (4) :254-258.
-
7Ossareh S, Asgari M, Abdi E,et al. Renal biopsy findings in Iran: case series report from a referral kidney center[ J]. Int Urol Neph- ro1,2010,42 (4) : 1031-1040.
-
8Sugiyama H, Yokoyam H, Sato H, et al. Japan Renal Biopsy Regis- try:the first nationwide, web-based, and prospective registry system of renal biopsies in Japan [ J ]. Clin Exp Nephrol, 2011,15 (4) : 493 -503.
-
9Zuo K, Wu Y, Li SJ, et al. Long term outcome and prognostic fac- tors of idiopathic membranous nephropathy in the Chinese popula- tion[ J]. Clin Nephrol,2013,79(6) :445-453.
-
10Cattran D. Management of membranous nephropathy: when and what for treatment [J]. J Am Soe Nephml, 2005, 16 (5): 1188-1194.
二级引证文献14
-
1李超,王春花,朱莺.用慢肾康颗粒对30例湿瘀互结型特发性膜性肾病患者进行治疗的效果探究[J].当代医药论丛,2018,16(22):170-172. 被引量:2
-
2戴梅,朱莺.清热活血护肾汤辅助治疗膜性肾病的效果探讨[J].当代医药论丛,2018,16(24):186-188. 被引量:1
-
3李振军,王建,李龙海,胡冬梅,董葆.膜性肾病的临床病理特征及流行病学特征探究[J].中国医学前沿杂志(电子版),2016,8(9):157-160. 被引量:5
-
4谢泉琨,党勇.火把花根片联合厄贝沙坦治疗特发性膜性肾病中度蛋白尿的疗效观察[J].中国中西医结合肾病杂志,2016,17(12):1070-1071. 被引量:17
-
5陈彦,范军.张大宁用补肾活血法治疗Ⅱ期特发性膜性肾病经验[J].实用中医药杂志,2017,33(9):1090-1091. 被引量:12
-
6周晶瀛.小剂量泼尼松联合他克莫司治疗特发性膜性肾病的临床价值[J].中国继续医学教育,2018,10(16):117-119. 被引量:9
-
7李伟皓,崔宝玲,高伟,张明明,刘晓梅,张菲菲,张智萍.血清PLA2R抗体评估原发性膜性肾病病情的临床价值研究[J].国际检验医学杂志,2018,39(23):2889-2892. 被引量:9
-
8余登,张尚瑜,邓秀清.他克莫司联合糖皮质激素治疗特发性膜性肾病的临床疗效观察[J].实用医院临床杂志,2018,15(2):41-43. 被引量:19
-
9李伟皓,董巍,刘丽霞,刘晓梅,张智萍,张菲菲.血清PLA2RAb阳性与阴性原发性膜性肾病患者实验室相关指标比较[J].山东医药,2018,58(46):20-23. 被引量:2
-
10陈生晓,林晓明,甘艳,高飞,尹纪来.膜性肾病组织中足细胞自噬体数量、自噬相关蛋白表达变化及其意义[J].山东医药,2019,59(8):73-75. 被引量:10
-
1黄定九.提高对心房颤动的认识和治疗水平——从基础到临床[J].中华心律失常学杂志,1998,2(4):245-246. 被引量:2
-
2黄定九.心房颤动的药物治疗[J].中华心律失常学杂志,1998,2(4):303-307. 被引量:3
-
3苏昕.肾病综合征并发血栓栓塞的临床分析[J].中华今日医学杂志,2004,4(6):22-23.
-
4石进,李雅君,张维君.心房颤动患者抗栓治疗后消化道出血的分析[J].中华消化杂志,2007,27(3):197-198.
-
5郭蔚,王肖龙.心房颤动的抗血栓治疗[J].世界临床药物,2007,28(3):147-151. 被引量:2
-
6郭英祥,胡锡衷.防治心房颤动并发血栓栓塞的研究进展[J].福建医药杂志,1999,21(1):97-99.
-
7田玲玲,黄留业.炎症性肠病与血栓栓塞性疾病[J].世界华人消化杂志,2017,25(7):589-595. 被引量:2
-
8孙艺红.心房颤动谨防脑卒中与血栓栓塞[J].家庭医学(上半月),2003,18(4):21-21.
-
9马春芬,党润芳,韩建伦.心房颤动并发血栓栓塞62例治疗分析[J].陕西医学杂志,2005,34(7):859-860.
-
10王锡三,汪惟实.心房颤动并发血栓栓塞危险因素的分析[J].心脏起搏与心电生理杂志,1995,9(4):203-204. 被引量:3